Literature DB >> 18082523

Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.

Marina Shor1, Mona Boaz, Dov Gavish, Julio Wainshtein, Zipora Matas, Marina Shargorodsky.   

Abstract

Haptoglobin (Hp) is an antioxidant protein and the major susceptibility gene for atherosclerosis in diabetic patients. The effect of Hp phenotype on arterial compliance and metabolic and inflammatory parameters was investigated. Patients were divided into 3 groups according to Hp phenotype of Hp 2-2, Hp 2-1, and Hp 1-1. Arterial elasticity of large and small arteries was evaluated using the pulse-wave contour analysis method. The large-artery elasticity index (LAEI) was lower in patients with Hp 2-2 compared with Hp 1-1 (8.4 +/- 2.3 vs 12.6 +/- 4.1 ml/mm Hg x 100; p <0.0001). The difference in LAEIs between the Hp 2-1 and Hp 1-1 groups was also significant (9.9 +/- 2.6 vs 12.6 +/- 4.1 ml/mm Hg x 100; p = 0.025). The Hp 2-2 and Hp 2-1 groups did not differ from one another. The small-artery elasticity index (SAEI) was significantly lower in patients with Hp 2-2 compared with Hp 1-1 (2.8 +/- 1.0 vs 4.4 +/- 1.9 ml/mm Hg x 100; p = 0.004). Differences in SAEIs between patients with Hp 2-1 and Hp 1-1, as well as those with Hp 2-1 and Hp 2-2, were not detected. Systemic vascular resistance differed significantly across groups, driven by the difference between patients with Hp 2-2 and Hp 1-1. In conclusion, LAEI and SAEI were significantly lower and systemic vascular resistance was higher in homozygotes for the 2 allele (Hp 2-2) compared with patients with Hp 2-1 or Hp 1-1 phenotypes. Differences in arterial elasticity were detected despite the lack of by-phenotype differences in glycemic control, blood pressure, or presence of cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082523     DOI: 10.1016/j.amjcard.2007.07.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Effects of lead and mercury on the blood proteome of children.

Authors:  Robert E Birdsall; Michael P Kiley; Zaneer M Segu; Christopher D Palmer; Milan Madera; Brooks B Gump; James A MacKenzie; Patrick J Parsons; Yehia Mechref; Milos V Novotny; Kestutis G Bendinskas
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

Review 2.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

3.  Haptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort.

Authors:  Tracey L Weissgerber; Paula L McGee; Leslie Myatt; John C Hauth; Michael W Varner; Ronald J Wapner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Philip Samuels; Anthony C Sciscione; Margaret Harper; George Saade; Yoram Sorokin
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-13

4.  Genetic determinants of circulating haptoglobin concentration.

Authors:  Nabila Kazmi; Yoshiro Koda; Ndeye Coumba Ndiaye; Sophie Visvikis-Siest; Matthew J Morton; Tom R Gaunt; Ian Galea
Journal:  Clin Chim Acta       Date:  2019-03-18       Impact factor: 3.786

5.  Evaluation of haptoglobin genotypes in patients with metabolic syndrome: A preliminary report.

Authors:  Alireza Nakhaee; Mohammad Hashemi; Alireza Rezaeifar; Mahmoud Ali Kaykhaei
Journal:  ARYA Atheroscler       Date:  2015-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.